Bnp Paribas Asset Management Holding S.A. Novavax Inc Transaction History
Bnp Paribas Asset Management Holding S.A.
- $41 Billion
- Q2 2025
A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Novavax Inc stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 1,286 shares of NVAX stock, worth $10,840. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,286Holding current value
$10,840% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding NVAX
# of Institutions
308Shares Held
94.2MCall Options Held
6.11MPut Options Held
10.7M-
Vanguard Group Inc Valley Forge, PA15.4MShares$130 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$99.9 Million0.0% of portfolio
-
Shah Capital Management11.5MShares$97 Million35.13% of portfolio
-
State Street Corp Boston, MA6.82MShares$57.5 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY3.94MShares$33.2 Million0.02% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $659M
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...